High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$15.0M
$15,030,000
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AKTS
P
Aktis Oncology, Inc.
Kim Helen Susan
• Director
Discretionary BuyΔOwn +16.7%
2026-01-12
$15,030,000MEGAx2
|
||||||
| AKTS |
Aktis Oncology, Inc.
|
Director
Discretionary BuyΔOwn +16.7%
|
2026-01-12 | $15,030,000MEGAx2 | P | Form 4 |